Peak6 Investments LLC Pro Qr Therapeutics N.V. Transaction History
Peak6 Investments LLC
- $43.5 Billion
- Q3 2024
A detailed history of Peak6 Investments LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Peak6 Investments LLC holds 100,000 shares of PRQR stock, worth $183,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$183,000% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PRQR
# of Institutions
82Shares Held
45.1MCall Options Held
31.4KPut Options Held
24.7K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.6MShares$17.6 Million0.05% of portfolio
-
Privium Fund Management B.V.4.99MShares$9.12 Million3.12% of portfolio
-
Woodline Partners LP San Francisco, CA3.56MShares$6.51 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$5.17 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.83MShares$5.17 Million1.38% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $131M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...